Literature DB >> 15273847

[Executive functions in children with phenylketonuria: variations as a function of phenilalanine plasm level].

Leandro Fernandes Malloy-Diniz1, Cláudia Cardoso-Martins, Karina Cunha Carneiro, Márcia Maria Magrille Cerqueira, Ana Paula Almeida Ferreira, Marcos José B de Aguiar, Ana Lúcia Starling.   

Abstract

The present study investigates the hypothesis of a specific executive function deficit in children with Phenilketonuria (PKU) whose Phenilalanine level is between 360 and 600 mmol/l. Participants were 21 early and continuously treated 9-month-old children with PKU and 18 9-month-old controls. The children with PKU were divided into two groups on the basis of their mean phenilalanine level prior to the study: the group of children whose level was between 120 and 360 mmol/l, and the group of children whose level was between 360 and 600 mmol/l. Although the three groups did not differ with regard to performance on a test of global mental development, the PKU children with high phenilalanine performed significantly worse than both the low phenilalanine PKU children and the control children on a task that assesses executive functioning.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15273847     DOI: 10.1590/s0004-282x2004000300018

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  2 in total

1.  Burden of phenylketonuria in Latin American patients: a systematic review and meta-analysis of observational studies.

Authors:  A L S Pessoa; A M Martins; E M Ribeiro; N Specola; A Chiesa; D Vilela; E Jurecki; D Mesojedovas; I V D Schwartz
Journal:  Orphanet J Rare Dis       Date:  2022-07-30       Impact factor: 4.303

2.  Quality of life and adherence to treatment in early-treated Brazilian phenylketonuria pediatric patients.

Authors:  E Vieira; H S Maia; C B Monteiro; L M Carvalho; T Tonon; A P Vanz; I V D Schwartz; M G Ribeiro
Journal:  Braz J Med Biol Res       Date:  2017-12-11       Impact factor: 2.590

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.